AU609834B2 - Treating agent for heart failure - Google Patents

Treating agent for heart failure Download PDF

Info

Publication number
AU609834B2
AU609834B2 AU18550/88A AU1855088A AU609834B2 AU 609834 B2 AU609834 B2 AU 609834B2 AU 18550/88 A AU18550/88 A AU 18550/88A AU 1855088 A AU1855088 A AU 1855088A AU 609834 B2 AU609834 B2 AU 609834B2
Authority
AU
Australia
Prior art keywords
heart failure
group
compound
pharmaceutically acceptable
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU18550/88A
Other languages
English (en)
Other versions
AU1855088A (en
Inventor
Shinichiro Ashida
Kiyoshi Irie
Satoshi Kunitada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU1855088A publication Critical patent/AU1855088A/en
Application granted granted Critical
Publication of AU609834B2 publication Critical patent/AU609834B2/en
Assigned to DAIICHI PHARMACEUTICAL CO., LTD. reassignment DAIICHI PHARMACEUTICAL CO., LTD. Amend patent request/document other than specification (104) Assignors: DAIICHI SEIYAKU CO. LTD.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatment Of Sludge (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU18550/88A 1987-07-01 1988-06-30 Treating agent for heart failure Ceased AU609834B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16438787 1987-07-01
JP62-164387 1987-07-01

Publications (2)

Publication Number Publication Date
AU1855088A AU1855088A (en) 1989-01-05
AU609834B2 true AU609834B2 (en) 1991-05-09

Family

ID=15792156

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18550/88A Ceased AU609834B2 (en) 1987-07-01 1988-06-30 Treating agent for heart failure

Country Status (12)

Country Link
US (1) US4933349A (cg-RX-API-DMAC10.html)
EP (1) EP0297593B1 (cg-RX-API-DMAC10.html)
JP (1) JPH01104013A (cg-RX-API-DMAC10.html)
KR (1) KR960007752B1 (cg-RX-API-DMAC10.html)
AT (1) ATE88634T1 (cg-RX-API-DMAC10.html)
AU (1) AU609834B2 (cg-RX-API-DMAC10.html)
CA (1) CA1309028C (cg-RX-API-DMAC10.html)
DE (1) DE3880564T2 (cg-RX-API-DMAC10.html)
DK (1) DK360388A (cg-RX-API-DMAC10.html)
IL (1) IL86846A (cg-RX-API-DMAC10.html)
PH (1) PH24636A (cg-RX-API-DMAC10.html)
ZA (1) ZA884697B (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
US5354770A (en) * 1989-02-27 1994-10-11 Daiichi Pharmaceutical Co., Ltd. Using imidazolyl tetrahydronaphthalene carboxylic acids to inhibit restenosis
ZA901416B (en) * 1989-02-27 1990-12-28 Daiichi Seiyaku Co Post-ptca restenosis inhibitor
WO1991015207A1 (en) * 1990-04-09 1991-10-17 Daiichi Pharmaceutical Co., Ltd. Remedy for obstructive pulmonary disease
AU2001247060A1 (en) * 2000-11-07 2002-05-21 Lozon Llc Splicing device and method for sealing conduit spaces
US10130267B2 (en) * 2012-03-08 2018-11-20 Medtronic, Inc. Heart sound monitoring of pulmonary hypertension

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665188A (en) * 1983-08-25 1987-05-12 Daiichi Seiyaku Co., Ltd. Certain [(1-imidazolyl)-lower-alkylene]-tetrahydronaphthalenecarboxylic acids or corresponding idan-carboxylic acids which are thromboxane A2

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665188A (en) * 1983-08-25 1987-05-12 Daiichi Seiyaku Co., Ltd. Certain [(1-imidazolyl)-lower-alkylene]-tetrahydronaphthalenecarboxylic acids or corresponding idan-carboxylic acids which are thromboxane A2

Also Published As

Publication number Publication date
JPH0552813B2 (cg-RX-API-DMAC10.html) 1993-08-06
CA1309028C (en) 1992-10-20
EP0297593B1 (en) 1993-04-28
DE3880564T2 (de) 1993-08-12
KR960007752B1 (ko) 1996-06-12
DK360388D0 (da) 1988-06-30
IL86846A (en) 1992-03-29
EP0297593A3 (en) 1990-08-01
PH24636A (en) 1990-08-17
EP0297593A2 (en) 1989-01-04
DE3880564D1 (de) 1993-06-03
DK360388A (da) 1989-01-02
AU1855088A (en) 1989-01-05
US4933349A (en) 1990-06-12
ZA884697B (en) 1989-03-29
ATE88634T1 (de) 1993-05-15
KR890001540A (ko) 1989-03-27
JPH01104013A (ja) 1989-04-21

Similar Documents

Publication Publication Date Title
EP1212081B2 (en) Use of ramipril in the prevention of congestive heart failure
JPH09510225A (ja) バルサルタンを用いる糖尿病性ネフロパシーの治療
US4933349A (en) Treating agent for heart failure
KR100210976B1 (ko) 항부정맥제
CA2320627C (en) Medicament for treatment of diastolic dysfunction
US4564625A (en) Binary compositions of penbutolol and furosemide or piretanide
US4086354A (en) Novel anti-hypertensive compositions
US6407113B1 (en) Medicament for treatment of diastolic dysfunction
US4315003A (en) Compositions containing azo compounds and use thereof for therapeutic treatment
AU609835B2 (en) Antidiabetic agent
US5747495A (en) Method for treating hypertension using pyrazolopyrimidine derivatives
US11413273B2 (en) Prophylactic or therapeutic agent for pulmonary hypertension comprising unsaturated 5-membered heterocycle-containing compound
US3821381A (en) Method of treatment
JPWO2003047591A1 (ja) 肺高血圧症予防治療剤
CN100398102C (zh) 含有草尿酸衍生物的肾衰竭用剂
US11154561B2 (en) Preventative or therapeutic agent for pulmonary hypertension including crude drug component
JPS625923A (ja) アレルギ−性疾患治療剤
US3721738A (en) Treatment and prophylaxis of thrombovascular diseases with 2-imidazolone derivatives
HU206612B (en) Process for producing antihypertenzive combinative composition
JPH0597669A (ja) 成人型呼吸窮迫症治療剤
JPH02240022A (ja) 心不全予防治療剤
JPS59155382A (ja) 麦角アルカロイド誘導体
JPH0418021A (ja) 血清尿酸低下剤
JPS61267522A (ja) 強心剤組成物
JPS6232727B2 (cg-RX-API-DMAC10.html)